Clinical Trials on Bioequivalence in Healthy Subjects

Total 1462 results

HK inno.N Corporation

Completed

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

Healthy Subjects

Korea, Republic of
Lyric Pharmaceuticals

Completed

A Study to Assess Ulimorelin in Healthy Subjects

Healthy Subjects
Tonix Pharmaceuticals, Inc.

Completed

Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules

Healthy Subjects

Canada
Cortexyme Inc.

Completed

Study of COR388 HCl in Healthy Subjects

Healthy Subjects

United States
Reckitt Benckiser Healthcare (UK) Limited

Terminated

Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.

Healthy Subjects
Pfizer

Completed

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

Healthy Subjects

United States
Curadim Pharma Co., Ltd.

Unknown

A First-in-human Phase 1 Study of CP1050

Healthy Subjects

United Kingdom
AstraZeneca

Completed

A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy Subjects

Healthy Subjects

United Kingdom
Charite University, Berlin, Germany

Completed

Walking for Stress Reduction

Healthy Subjects

Germany
Diurnal Limited
Simbec Research

Completed

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions

Healthy Subjects
Da Volterra

Completed

Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

Healthy Subjects

France
Nicox Ophthalmics, Inc.
ORA, Inc.

Completed

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects

United States
Minerva Neurosciences

Completed

A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects

Healthy Subjects

Ireland
Lee's Pharmaceutical Limited

Completed

Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense System)

Healthy Subjects

Hong Kong
Norwegian University of Science and Technology

Completed

Cardiovascular Fitness and Venous Function in Trained and Untrained Subjects

Healthy Subjects

Norway
Egalet Ltd

Completed

Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device

Healthy Subjects

United Kingdom
Verastem, Inc.

Completed

A Phase I, Open-label Study of Absorption, Metabolism, and Excretion of Defactinib (VS-6063) in Healthy Male Subjects

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

Healthy Subjects
Actelion

Completed

Comparison of Two Dose Strengths of Selexipag in Healthy Adults

Healthy Subjects

Germany
Lund University
Anti-Diabetic Food Centre

Completed

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

Healthy Subjects

Sweden
Pfizer

Completed

A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects (B538-05)

Healthy Subjects

United States
University Hospital, Linkoeping

Completed

Effects of Red Wine on Cardiovascular Risk Factors in Humans

Healthy Subjects
Charite University, Berlin, Germany

Completed

Effects of Brain Stimulation During Daytime Nap on Memory Consolidation in Younger, Healthy Subjects

Healthy Subjects

Germany
Eisai Co., Ltd.

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects

Japan
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Healthy Subjects
Eisai Co., Ltd.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects

Healthy Subjects

Japan
Eisai Inc.

Completed

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

Healthy Subjects

United States
Eisai Inc.

Completed

A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

Healthy Subjects

United States
Eisai Inc.

Completed

A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects

Healthy Subjects
Celgene Corporation

Completed

Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study

Healthy Subjects

United States
Astellas Pharma Europe B.V.

Completed

A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects

Healthy Subjects

United Kingdom
LG Life Sciences

Completed

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

Healthy Subjects
Pfizer

Completed

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) (B538-07)

Healthy Subjects

United States
Maastricht University Medical Center

Completed

Electrophysiological Reactivity Due to Mobile Phone Radiation

Healthy Subjects

Netherlands
GlaxoSmithKline

Withdrawn

Bioequivalence Study of SB797620 in Healthy Japanese Volunteers

Healthy Subjects
GlaxoSmithKline

Withdrawn

A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib

Healthy Subjects

United States
AstraZeneca
Celerion

Completed

Autoinjector Device Assessment Study (BCB119)

Healthy Subjects

United States
GlaxoSmithKline

Completed

A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype

Healthy Subjects

United States
GlaxoSmithKline

Completed

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®

Healthy Subjects

United States
Eisai Inc.

Completed

A Study to Evaluate the Effects of Diltiazem, a Moderate CYP3A4/A5 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of E5555 and Its Metabolites in Healthy Subjects

Healthy Subjects

Netherlands
Cliniques universitaires Saint-Luc- Université...

Unknown

Comparison of Lung Administration With Three Different Nebulizer

Healthy Subjects

Belgium
Medtronic - MITG

Completed

Pulse Oximetry- Evaluating Resp Rate- PCBA-1

Healthy Subjects

United States
Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

Healthy Subjects

United States
Yonsei University

Completed

The Effect of Nicardipine on Kidney Function During Orthognathic Surgery Under Hypotensive Anesthesia

Healthy Subjects
University of Helsinki
Finnish Institute of Occupational Health; SalWe Ltd.

Completed

The Effects of Breakfast on Mental Workload (AivoPro1)

Healthy Subjects

Finland
American Regent, Inc.

Completed

Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects

Healthy Subjects

United States
Chonbuk National University Hospital

Completed

A Human Trial to Evaluate the Effects of Chungkookjang on Histamine-induced Wheal Size in Healthy Subjects

Healthy Subjects

Korea, Republic of
UCB Pharma

Completed

A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

Healthy Subjects

United States

3

Subscribe